Searched for
INDIAN IMMUNOLOGICALS
Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%At a time when there are so many headwinds for the markets, it is tough to imagine that things can get better. But sentiment is a fickle th...- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...
- Overhaul of drug regulator begins with recruitment plan for 1,500 specialistsIndia's pharmaceutical landscape is on the verge of transformation! The country’s drug regulatory body is gearing up for an overhaul with t...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%In these times of geopolitical stress, how will things pan out for the Indian market? Will it be a standalone underperformer? Or is it just...
- Biocon rolls out two biosimilars in US marketBiocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They...
- Veterinary vaccine firms form association for collaboration with policymakersIndia's leading veterinary vaccine manufacturers, including Hester Biosciences and Indian Immunologicals, have formed the Veterinary Vaccin...
- Indian Immunologicals targets dengue vaccine launch by January 2026Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top execu...
- IIL to make 10 million doses of Covaxin drug substance from DecemberIndian Immunologicals' Managing Director K Anand Kumar informed that IIL is also working on an attenuated COVID-19 vaccine which is likely ...
- State-owned BIBCOL set to begin production of Bharat Bio's Covaxin by February 2022The government is now betting on Indian Immunologicals to boost Covaxin production this year as Haffkine Bio-Pharma managing director Sande...
- Bharat Biotech ties up with IIL for Covaxin materialHyderabad-based IIL, part of the NDDB, said it will send out the first batch of the drug ingredient to Bharat Biotech by July.
- What's in a name? It can give a stock 400% leapWhile Bharat Biotech is competing to develop India’s first vaccine for the pandemic, shares of a little-known state-owned company — Bharat ...
- Hyderabad company, Australian varsity partner for vaccineScientists from India and Australia will develop a ‘live attenuated SARS – CoV-2 vaccine’ using the latest codon deoptimisation technology,...
- IIL set to expand its protozoan Vaccine portfolioInstituto Nacional de Tecnologia Agropecuaria (INTA) is Argentina’s federal agency in charge of the generation, adaptation and diffusion of...
- NDDB-arm develops world’s first vaccine against tapeworms in pigsIIL has obtained the license the to manufacture and market the vaccine after conducting extensive field trials in India and many other coun...
- IIL opens 'New Bovine Serum' manufacturing unit in New ZealandBiologicals company Indian Immunologicals Limited (IIL) today inaugurated its 'New Bovine Serum' manufacturing plant in New Zealand.
- Indian Immunologicals to unveil feed for lab animals used for clinical trialsAt present, India houses hundreds of scientific bodies, both in public and private sectors, which together have nearly 10 million lab anima...
- Indian Immunologicals plans Rs 300 crore vaccine plant in PondicherryHyderabad headquartered vaccine manufacturer Indian Immunologicals Ltd (IIL), part of the National Dairy Development Board, is setting up a...
- Indian Immunologicals Ltd produces 1 bn doses of Foot and Mouth disease vaccineIndian Immunologicals Ltd, a wholly owned subsidiary of NDDB, has produced one billion doses of the Foot and Mouth Disease Vaccine.
- Indian Immunologicals to launch 4 vaccines in a yearIndian Immunologicals Ltd, a subsidiary of National Dairy Development Board, today said it will launch four vaccines in the next one year a...
Load More
